Biocompatible breast implants manufactured by BellaSeno now ISO standard certified
Biotech start-up BellaSenso raised an additional $1.126m to conduct clinical trial for its biocompatible and absorbable breast implants…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Jul 19
Biotech start-up BellaSenso raised an additional $1.126m to conduct clinical trial for its biocompatible and absorbable breast implants…
15 Jul 19
Neovasc has received guidance from the Food and Drug Administration (FDA) to consider potential alternate approaches for Humanitarian…
15 Jul 19
Medigus has achieved the additional milestone and received an order for 1,400 units of the integrated visualization device…
15 Jul 19
Masimo has announced that in a study, researchers have investigated the ability of its Masimo Oxygen Reserve Index…
15 Jul 19
UK-based medical technology company Smith & Nephew has announced 0% re-operation rate and 100% meniscal healing at six…
12 Jul 19
Healthy.io released a joint study with researchers from the Johns Hopkins University School of Medicine measuring the feasibility…
12 Jul 19
Meril's recently CE-approved MeRes100, used for the treatment of de-novo coronary artery lesions, has demonstrated zero scaffold thrombosis…
12 Jul 19
Results showing arthroscopic surgery for knee problems is more accurate than MRI were presented at the Orthopedic Society…
Philips is pioneering research into the next generation of CT imaging: Spectral Photon Counting CT (SPCCT), as part…
Keystone Heart announced that it has signed a distribution agreement with Ireland-based Vasorum for sales and marketing of…